The Neurodegeneration Imaging Group (NIG), directed by Professor Marios Politis. Part of @UniofExeter @ExeterMed focused on #PETimaging#MRI#neurodegeneration
Sign up to #parkinsons studies at our @Exeter_MGNC to test whether a new drug which reduces brain inflammation could become a future treatment.
Great to see this story on @BBCDevon today. Huge thanks to Tim for sharing his story.
https://t.co/WwQhEGYMQZ
Tau PET is an attractive biomarker for Alzheimer’s disease but is not readily accessible to patients. Lee et al. present an AI model that can impute tau PET images from more widely available cross-modality imaging inputs. https://t.co/gLEVJmGExW
Kepp et al. review the amyloid cascade hypothesis of Alzheimer’s disease in light of new evidence from clinical trials of anti-amyloid antibodies, and argue that the data point to amyloid playing a relatively minor aetiological role. https://t.co/TtWzwjgom2
The Alzheimer's Disease Neuroimaging Initiative in the era of #alzheimersdisease treatment: A review of ADNI studies from 2021 to 2022
https://t.co/y1Id12qbio